The FDA has issued a warning letter to Novo Nordisk for violating postmarketing adverse drug experience regulations that include failure to report adverse events among patients taking GLP-1s. Chronic ...

Astral has broken out above a long consolidation range in recent sessions, clearing the Rs 1,590–1,596 zone with conviction. The price now trades comfortably above all key EMAs, which are sloping ...

Depending on whether you have a form of diabetes, are prediabetic, or are merely watching your blood sugar, you will have different strategies for managing your glucose levels. But regardless of ...

Strategic diet choices can help you hit your A1C goal. Check out these expert-approved picks that offer bonus health perks.